Filing Details

Accession Number:
0001567619-19-000984
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-10 18:32:38
Reporting Period:
2018-12-17
Accepted Time:
2019-01-10 18:32:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422143 Kura Oncology Inc. KURA Pharmaceutical Preparations (2834) 611547851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598292 Ecor1 Capital Fund Qualified, L.p. 409 Illinois Street
San Francisco CA 94158
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-17 26,520 $13.20 4,194,209 No 4 S Direct
Common Stock Acquisiton 2018-12-18 78,469 $13.82 4,272,678 No 4 P Direct
Common Stock Acquisiton 2018-12-19 51,879 $13.84 4,324,557 No 4 P Direct
Common Stock Acquisiton 2018-12-21 83,540 $13.16 4,408,097 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct